Not-for-profit healthcare organisation Carilion Clinic is set to provide needle-free blood draws to patients leveraging Becton, Dickinson and Company’s (BD) blood collection device. This initiative to ...

Chicago (tca/dpa) — The practice of drawing blood has changed very little over the decades. It looks about the same now as it did 50 years ago. That process, however, may be about to get a modern ...

The practice of drawing blood has changed very little over the decades. It looks about the same now as it did 50 years ago. That process, however, may be about to get a modern makeover. Several health ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. Hannah Koczka, Vice President of ...

BD’s new MiniDraw diagnostic devices could let pharmacists—and, one day, maybe patients—manage blood testing needs and monitor health conditions. BD received its FDA authorizations for two blood draw ...

Chicago-based Northwestern Medicine is collaborating with Netherlands-based medical robotics company Vitestro to test whether automated blood draw devices can be a scalable solution for U.S. hospitals ...

Capillary device supports in-office blood collection in diverse practice locations without the need for venipuncture BOULDER, Colo.--(BUSINESS WIRE)-- Biodesix, Inc. (Nasdaq: BDSX), a leading ...

Not long after locking down FDA clearance for a device used to collect high-volume blood samples from the comfort of a user’s own home, Tasso is once again expanding its reach—both geographically and ...

The device, called Tap, collects capillary blood for hemoglobin A1c testing, which is commonly used to monitor blood sugar levels in diabetic or pre-diabetic patients, according to a news release. To ...

CHICAGO — The practice of drawing blood has changed very little over the decades. It looks about the same now as it did 50 years ago. That process, however, may be about to get a modern makeover.

BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today the validation and launch of a new method of ...